These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 23653479)
1. Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease. Du L; Bergsneider M; Mirsadraei L; Young SH; Jonker JW; Downes M; Yong WH; Evans RM; Heaney AP Proc Natl Acad Sci U S A; 2013 May; 110(21):8555-60. PubMed ID: 23653479 [TBL] [Abstract][Full Text] [Related]
2. Targeting the ERK pathway for the treatment of Cushing's disease. Zhang D; Bergsneider M; Wang MB; Heaney AP Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250 [TBL] [Abstract][Full Text] [Related]
3. Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease. Zhang D; Damoiseaux R; Babayan L; Rivera-Meza EK; Yang Y; Bergsneider M; Wang MB; Yong WH; Kelly K; Heaney AP J Clin Endocrinol Metab; 2021 Jan; 106(1):e232-e246. PubMed ID: 33000123 [TBL] [Abstract][Full Text] [Related]
4. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169 [TBL] [Abstract][Full Text] [Related]
5. A human ACTH-secreting corticotroph tumoroid model: Novel Human ACTH-Secreting Tumor Cell in vitro Model. Zhang D; Hugo W; Redublo P; Miao H; Bergsneider M; Wang MB; Kim W; Yong WH; Heaney AP EBioMedicine; 2021 Apr; 66():103294. PubMed ID: 33773184 [TBL] [Abstract][Full Text] [Related]
6. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease. Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479 [TBL] [Abstract][Full Text] [Related]
7. Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells. Xia L; Shen D; Zhang Y; Lu J; Wang M; Wang H; Chen Y; Xue D; Xie D; Li G J Cell Mol Med; 2021 Mar; 25(5):2404-2417. PubMed ID: 33491272 [TBL] [Abstract][Full Text] [Related]
8. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas. Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo. Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056 [TBL] [Abstract][Full Text] [Related]
10. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway. Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322 [TBL] [Abstract][Full Text] [Related]
11. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease. Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962 [TBL] [Abstract][Full Text] [Related]
12. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation. Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells. Nakada Y; Kageyama K; Sugiyama A; Desaki R; Takayasu S; Niioka K; Murasawa S; Ishigame N; Asari Y; Iwasaki Y; Daimon M Endocr J; 2015; 62(12):1083-90. PubMed ID: 26497760 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells. Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813 [TBL] [Abstract][Full Text] [Related]
16. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013 [TBL] [Abstract][Full Text] [Related]
17. FAF1 Gene Involvement in Pituitary Corticotroph Tumors. Nguyen M; Maria AG; Faucz FR; Trivellin G; Stratakis CA; Tatsi C Horm Metab Res; 2024 Aug; 56(8):604-610. PubMed ID: 38065537 [TBL] [Abstract][Full Text] [Related]
18. PATHOGENESIS OF CUSHING DISEASE: AN UPDATE ON THE GENETICS OF CORTICOTROPINOMAS. Albani A; Perez-Rivas LG; Reincke M; Theodoropoulou M Endocr Pract; 2018 Oct; 24(10):907-914. PubMed ID: 30084690 [TBL] [Abstract][Full Text] [Related]
19. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease. Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046 [TBL] [Abstract][Full Text] [Related]
20. Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Liu NA; Jiang H; Ben-Shlomo A; Wawrowsky K; Fan XM; Lin S; Melmed S Proc Natl Acad Sci U S A; 2011 May; 108(20):8414-9. PubMed ID: 21536883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]